As a pioneering CDMO to the psychedelic sector, Psygen is building the foundation for a disruption in mental health and wellness. Improved access to GMP psychedelics is critical to the discovery and commercialization of new and effective medicines.
The Psychedelics Industry Needs a Dedicated Manufacturer
Psygen’s 17,000 sq. ft. state-of-the art, GMP-compliant facility will enable large-scale synthesis of psychedelic compounds in a production area of 6,000 sq. ft.
Psygen has received a Health Canada dealer’s license which allows the manufacture, sale, import, export, and analysis of LSD, 2C-B, DMT, MDMA, psilocybin, and mescaline.
Psygen API Catalogue
TRYPTAMINES ~ PHENYLETHYLAMINES ~ ERGOLINES
Psygen offers unparalleled knowledge and manufacturing capabilities from over 50 years of experience in manufacturing psychedelic medicines.
We are proud to offer the ability to create custom compounds.
Psilocybin
MDMA
DMT
LSD
Mescaline
2C-B
5-MeO-DMT
Ibogaine
Expanding Access
Global access to pharmaceutical grade psychedelics is limited. Psygen works for the benefit and advancement of the psychedelic industry to expand and serve new markets.
